{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:25:10Z","timestamp":1790425510640,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Mass Spectrometry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ijms.2020.116370","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T20:38:32Z","timestamp":1592253512000},"page":"116370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Tandem mass spectrometry of small-molecule antiviral drugs: 1. HIV-related antivirals"],"prefix":"10.1016","volume":"455","author":[{"given":"W.M.A.","family":"Niessen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijms.2020.116370_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/br.35.3.235-241.1971","article-title":"Expression of animal virus genomes","volume":"35","author":"Baltimore","year":"1971","journal-title":"Bacteriol Rev Sep"},{"key":"10.1016\/j.ijms.2020.116370_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0021-9673(98)00281-7","article-title":"Analysis of antibiotics by liquid chromatography - mass spectrometry","volume":"812","author":"Niessen","year":"1998","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.ijms.2020.116370_bib3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/mas.20332","article-title":"Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography\u2013tandem mass spectrometry","volume":"30","author":"Niessen","year":"2011","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.ijms.2020.116370_bib4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jms.3219","article-title":"Tandem mass spectrometry study of p38a kinase inhibitors and related substances","volume":"48","author":"Falck","year":"2013","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib5","series-title":"Interpretation of MS-MS Mass Spectra of Drugs and Pesticides (ISBN 978-1-118-50018-7)","author":"Niessen","year":"2017"},{"key":"10.1016\/j.ijms.2020.116370_bib6","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s00216-010-3986-z","article-title":"Therapeutic drug monitoring by LC\u2013MS\u2013MS with special focus on anti-infective drugs","volume":"398","author":"M\u00fcller","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ijms.2020.116370_bib7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jpba.2017.07.003","article-title":"Current antiviral drugs and their analysis in biological materials - Part II: antivirals against hepatitis and HIV viruses","volume":"147","author":"Nov\u00e1kov\u00e1","year":"2018","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4155\/bio.12.319","article-title":"Antiretroviral bioanalysis methods of tissues and body biofluids","volume":"5","author":"DiFrancesco","year":"2013","journal-title":"Bioanalysis"},{"issue":"12","key":"10.1016\/j.ijms.2020.116370_bib9","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1080\/17512433.2016.1235972","article-title":"Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients","volume":"9","author":"Punyawudho","year":"2016","journal-title":"Expert Rev Clin Pharmacol Dec"},{"issue":"3","key":"10.1016\/j.ijms.2020.116370_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.NPR.0000653948.44968.cc","article-title":"New drug treatment options for HIV antiretroviral therapy","volume":"45","author":"Kwong","year":"2020","journal-title":"Nurs. Pract."},{"key":"10.1016\/j.ijms.2020.116370_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0009-9120(02)00286-2","article-title":"Simple rapid method for quantification of antiretrovirals by liquid chromatography-tandem mass-spectrometry","volume":"35","author":"Volosov","year":"2002","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ijms.2020.116370_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1570-0232(03)00039-4","article-title":"Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography-mass spectrometry","volume":"788","author":"Rentsch","year":"2003","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jms.425","article-title":"Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry","volume":"38","author":"Crommentuyn","year":"2003","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib14","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/rcm.3119","volume":"21","author":"ter Heine","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib15","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jchromb.2009.04.046","article-title":"Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS\/MS) method for the quantitative determination of 10 antiretrovirals in human peripheral blood mononuclear cells","volume":"877","author":"Elens","year":"2009","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/FTD.0b013e3181c05adf","article-title":"Validation of an electrospray ionization LC-MS\/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples","volume":"31","author":"Quaranta","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ijms.2020.116370_bib17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jchromb.2010.03.036","article-title":"Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS\/MS) assay for the simultaneous determination of existing and new antiretroviral compounds","volume":"878","author":"Else","year":"2010","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpba.2013.08.002","article-title":"Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS\/MS technology","volume":"86","author":"Djerada","year":"2013","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpba.2017.02.002","article-title":"UPLC-MS\/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma","volume":"138","author":"Simiele","year":"2017","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchromb.2018.03.021","article-title":"Simultaneous determination of antiretroviral drugs in human hair with liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"1083","author":"Wu","year":"2018","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.17145\/jab.18.007","article-title":"Development and validation of a bioanalytical method for the simultaneous determination of 14 antiretroviral drugs using liquid chromatography-tandem mass spectrometry","volume":"4","author":"Daskapan","year":"2018","journal-title":"J\u00a0Appl Bioanal"},{"key":"10.1016\/j.ijms.2020.116370_bib22","article-title":"HPLC-MS\/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-\u03b2-d-glucuronide in human plasma","volume":"182","author":"Zheng","year":"2020","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib23","article-title":"UPLC-MS\/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma","volume":"181","author":"Gouget","year":"2020","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cca.2014.03.016","article-title":"The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood","volume":"433","author":"Marzinke","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijms.2020.116370_bib25","author":"Agilent Technologies"},{"key":"10.1016\/j.ijms.2020.116370_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jms.752","article-title":"Development and validation of a liquid chromatographic\/tandem mass spectrometric assay for the quantitation of nucleoside HIV reverse transcriptase inhibitors in biological matrices","volume":"40","author":"Compain","year":"2005","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib27","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.jchromb.2011.07.045","article-title":"Comprehensive analysis of the intracellular metabolism of antiretroviral nucleosides and nucleotides using liquid chromatography\u2013tandem mass spectrometry and method improvement by using ultra performance liquid chromatography","volume":"879","author":"Coulier","year":"2011","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2008.04.012","article-title":"Nucleoside reverse transcriptase inhibitors and their phosphorylated metabolites in human immunodeficiency virus-infected human matrices","volume":"868","author":"Lai","year":"2008","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/rcm.1329","article-title":"Determination of Abacavir in maternal plasma, amniotic fluid, fetal and placental tissues by a polarity switching liquid chromatography\/tandem mass spectrometry method","volume":"18","author":"Clark","year":"2004","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jchromb.2005.04.003","article-title":"Simultaneous analysis of several antiretroviral nucleosides in rat-plasma by high-performance liquid chromatography with UV using acetic acid\/hydroxylamine buffer. Test of this new volatile medium-pH for HPLC-ESI-MS\/MS","volume":"821","author":"Bezy","year":"2005","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jchromb.2006.12.015","article-title":"Simultaneous measurement of intracellular triphosphate metabolites of zidovudine, lamivudine and abacavir (carbovir) in human peripheral blood mononuclear cells by combined anion exchange solid phase extraction and LC-MS\/MS","volume":"850","author":"Robbins","year":"2007","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib37","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1021\/ac902737j","article-title":"Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography-tandem mass spectrometry","volume":"82","author":"Fromentin","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijms.2020.116370_bib39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jms.1294","article-title":"Specificity enhancement with LC-positive ESI-MS\/MS for the measurement of nucleotides: application to the quantitative determination of carbovir triphosphate, lamivudine triphosphate and tenofovir diphosphate in human peripheral blood mononuclear cells","volume":"43","author":"Pruvost","year":"2008","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib40","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jchromb.2009.11.041","article-title":"Simultaneous determination of didanosine and its amino acid prodrug, valdidanosine by hydrophilic interaction chromatography coupled with electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study in rats","volume":"878","author":"Yan","year":"2010","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib36","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.jchromb.2009.09.007","article-title":"On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors","volume":"877","author":"Kuklenyik","year":"2009","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/bmc.169","article-title":"Determination of lamivudine\/stavudine\/efavirenz in human serum using liquid chromatography\/electrospray tandem mass spectrometry with ionization polarity switch","volume":"16","author":"Fan","year":"2002","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijms.2020.116370_bib41","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0731-7085(00)00248-X","article-title":"Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry","volume":"22","author":"Kenney","year":"2000","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib42","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/rcm.8510","article-title":"Spatial distribution of elvitegravir and tenofovir in rat brain tissue: application of matrix-assisted laser desorption\/ionization mass spectrometry imaging and liquid chromatography\/tandem mass spectrometry","volume":"33","author":"Ntshangase","year":"2019","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jpba.2017.08.028","article-title":"Simultaneous determination of tenofovir alafenamide and its active metabolites tenofovir and tenofovir diphosphate in HBV-infected hepatocyte with a sensitive LC-MS\/MS method","volume":"146","author":"Ouyang","year":"2017","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpba.2018.04.035","article-title":"Development and validation of an LC-MS\/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid","volume":"156","author":"Ocque","year":"2018","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/rcm.605","article-title":"Improved method for the simultaneous determination of d4T, 3TC and ddl intracellular phosphorylated anabolites in human peripheral-blood mononuclear cells using high-performance liquid chromatography\/tandem mass spectrometry","volume":"16","author":"Becher","year":"2002","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jchromb.2018.12.008","article-title":"Development and validation of an UPLC-MS\/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma","volume":"1105","author":"Bollen","year":"2019","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jpba.2008.10.002","article-title":"Study of forced decomposition behavior of lamivudine using LC, LC-MS\/TOF and MSn","volume":"49","author":"Bedse","year":"2009","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jpba.2010.08.021","article-title":"Separation and characterization of forced degradation products of abacavir sulphate by LC-MS\/MS","volume":"54","author":"Rao","year":"2011","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jssc.201300959","article-title":"LC-MS\/MS method for the characterization of the forced degradation products of Entecavir","volume":"37","author":"Ramesh","year":"2014","journal-title":"J.\u00a0Separ. Sci."},{"key":"10.1016\/j.ijms.2020.116370_bib33","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1016\/j.chroma.2010.06.062","article-title":"Determination of nucleotides, nucleosides and their transformation products in Cordyceps by ion-pairing reversed-phase liquid chromatography-mass spectrometry","volume":"1217","author":"Yang","year":"2010","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.ijms.2020.116370_bib47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/bmc.1125","volume":"23","author":"Nirogi","year":"2009","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijms.2020.116370_bib48","doi-asserted-by":"crossref","first-page":"96117","DOI":"10.1039\/C5RA17532A","article-title":"Stability behaviour of antiretroviral drugs and their combinations. 1: characterization of tenofovir disoproxil fumarate degradation products by mass spectrometry","volume":"5","author":"Kurmi","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijms.2020.116370_bib49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpba.2016.08.022","article-title":"Stability behaviour of antiretroviral drugs and their combinations. 4: characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate","volume":"131","author":"Golla","year":"2016","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib113","doi-asserted-by":"crossref","unstructured":"Niessen W.M.A., Tandem mass spectrometry of small-molecule antiviral drugs: 2. Hepatitis-related antivirals, Int. J. Mass Spectrom. (In press), doi:10.1016\/j.ijms.2020.116371.","DOI":"10.1016\/j.ijms.2020.116371"},{"key":"10.1016\/j.ijms.2020.116370_bib50","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.4155\/bio.13.256","article-title":"The development and validation of an UHPLC-MS\/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma","volume":"5","author":"Seserko","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ijms.2020.116370_bib51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jpba.2014.06.018","article-title":"Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS\/MS) analysis","volume":"98","author":"Parsons","year":"2014","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/jms.4506","article-title":"Development and validation of a multiplex UHPLC-MS\/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV","volume":"55","author":"Courlet","year":"2020","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib53","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.jchromb.2009.07.031","article-title":"A\u00a0liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV","volume":"877","author":"Martin","year":"2009","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.chemosphere.2018.02.105","article-title":"LC-MS\/MS determination of antiretroviral drugs in influents and effluents from wastewater treatment plants in KwaZulu-Natal, South Africa","volume":"200","author":"Abafe","year":"2018","journal-title":"Chemosphere"},{"key":"10.1016\/j.ijms.2020.116370_bib55","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jchromb.2009.02.057","article-title":"A\u00a0LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: raltegravir, maraviroc, darunavir, and etravirine","volume":"877","author":"Fayet","year":"2009","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jpba.2016.08.016","article-title":"Development and validation of a liquid chromatographic-tandem mass spectrometric method for the multiplexed quantification of etravirine, maraviroc, raltegravir, and rilpivirine in human plasma and tissue","volume":"131","author":"Parsons","year":"2016","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib57","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.jchromb.2010.09.016","article-title":"LC-MS\/MS determination of etravirine in rat plasma and its application in pharmacokinetic studies","volume":"878","author":"Abobo","year":"2010","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/dta.1665","article-title":"Reliable LC-MS\/MS assay for the estimation of rilpivirine in human plasma: application to a bioequivalence study and incurred sample reanalysis","volume":"7","author":"Gupta","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib59","first-page":"814","article-title":"Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys","volume":"25","author":"Chang","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib60","first-page":"828","article-title":"Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice","volume":"25","author":"Chang","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib61","first-page":"631","article-title":"Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3A","volume":"26","author":"Voorman","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib62","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/jms.3807","article-title":"Characterization of impurities of HIV NNRTI Doravirine by UHPLC-high resolution MS and tandem MS analysis","volume":"51","author":"Zhang","year":"2016","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib63","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jpba.2017.09.029","article-title":"Stability behaviour of antiretroviral drugs and their combinations. 8: characterization and in-silico toxicity prediction of degradation products of efavirenz","volume":"148","author":"Kurmi","year":"2018","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib64","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejps.2018.03.026","article-title":"High resolution mass spectrometry-based methodologies for identification of Etravirine bioactivation to reactive metabolites: in\u00a0vitro and in\u00a0vivo approaches","volume":"119","author":"Godinho","year":"2018","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ijms.2020.116370_bib65","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1124\/dmd.111.044404","article-title":"Biotransformation of the antiretroviral drug etravirine: metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolism","volume":"40","author":"Yanakakis","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib66","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.clinbiochem.2015.12.011","volume":"49","author":"Belkhir","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ijms.2020.116370_bib67","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1128\/AAC.01401-13","article-title":"Human biotransformation of the nonnucleoside reverse transcriptase inhibitor rilpivirine and a cross-species metabolism comparison","volume":"57","author":"Lade","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijms.2020.116370_bib68","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/bmc.2765","article-title":"Liquid chromatography-tandem mass spectrometric assay for the non-nucleoside reverse transcriptase inhibitor rilpivirine in human plasma","volume":"27","author":"Burugula","year":"2013","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijms.2020.116370_bib69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jchromb.2005.09.032","article-title":"Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry","volume":"829","author":"Dickinson","year":"2005","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1570-0232(03)00063-1","article-title":"Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography-tandem mass spectrometry following automated solid-phase extraction","volume":"788","author":"Schuster","year":"2003","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib71","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/dmd.31.3.275","article-title":"Oxidative metabolism of amprenavir in the human liver. Effect of the CYP3A maturation","volume":"31","author":"Tr\u00e9luyer","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib72","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jchromb.2004.01.041","article-title":"Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry","volume":"804","author":"Crommentuyn","year":"2004","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib73","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jms.3201","article-title":"Identification and structural elucidation of in\u00a0vitro metabolites of atazanavir by HPLC and tandem mass spectrometry","volume":"48","author":"Cheng","year":"2013","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib74","doi-asserted-by":"crossref","first-page":"19113","DOI":"10.1039\/C8NJ03418D","article-title":"Study of forced degradation behaviour of cobicistat and atazanavir using LC\/ESI\/QTOF\/MS; a combination of in-sourced and collision-induced dissociation for evaluation of the fragmentation patterns of degradation products","volume":"42","author":"Baira","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.ijms.2020.116370_bib75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1872312810666160303112212","article-title":"Biotransformation of cobicistat: metabolic pathways and enzymes","volume":"10","author":"Wang","year":"2016","journal-title":"Drug Metabol. Lett."},{"key":"10.1016\/j.ijms.2020.116370_bib76","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/(SICI)1097-0231(19981130)12:22<1756::AID-RCM381>3.0.CO;2-C","article-title":"Identification of drug metabolites in biological matrices by intelligent automated liquid chromatography\/tandem mass spectrometry","volume":"12","author":"Lopez","year":"1998","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1044-0305(98)00132-9","article-title":"Identification of in\u00a0vitro metabolites of indinavir by \"intelligent automated LC-MS\/MS\" (INTAMS) utilizing triple quadrupole tandem mass spectrometry","volume":"10","author":"Yu","year":"1999","journal-title":"J.\u00a0Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-9673(02)01243-8","article-title":"Structural elucidation of metabolites of ritonavir and indinavir by liquid chromatography-mass spectrometry","volume":"974","author":"Gangl","year":"2002","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.ijms.2020.116370_bib79","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1021\/ac034980s","article-title":"Integration of knowledge-based metabolic predictions with liquid chromatography data-dependent tandem mass spectrometry for drug metabolism studies: application to studies on the biotransformation of indinavir","volume":"76","author":"Anari","year":"2004","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijms.2020.116370_bib80","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpba.2012.10.025","article-title":"Liquid chromatography tandem mass spectrometric studies of indinavir sulphate and its forced degradation products","volume":"74","author":"Rao","year":"2013","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib81","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0090-9556(24)14888-X","article-title":"In\u00a0vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification","volume":"27","author":"Kumar","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/dmd.111.041400","article-title":"CYP3A4-mediated lopinavir bioactivation and its inhibition by ritonavir","volume":"40","author":"Li","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib83","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jchromb.2014.10.032","article-title":"Simultaneous determination of lopinavir and three ester prodrugs by LC-MS\/MS in lysates of BeWo cells","volume":"975","author":"Wang","year":"2015","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib84","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jpba.2011.02.020","article-title":"LC, LC-MS\/TOF and MSn studies for the identification and characterization of degradation products of nelfinavir mesylate","volume":"55","author":"Tiwari","year":"2011","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib85","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpba.2015.10.023","article-title":"Identification of stable and reactive metabolite(s) of nelfinavir in human liver microsomes and rCYP3A4","volume":"118","author":"Jhajra","year":"2016","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib86","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpba.2010.06.004","article-title":"LC-MS\/MS studies of ritonavir and its forced degradation products","volume":"53","author":"Rao","year":"2010","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib87","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/rcm.7842","article-title":"Identification of degradation products of saquinavir mesylate by ultra-high-performance liquid chromatography\/electrospray ionization quadrupole time-of-flight tandem mass spectrometry and its application to quality control","volume":"31","author":"Thummar","year":"2017","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib91","doi-asserted-by":"crossref","first-page":"e4379","DOI":"10.1002\/bmc.4379","article-title":"Development and validation of LC-MS\/MS method for quantification of bictegravir in human plasma and its application to an intracellular uptake study","volume":"33","author":"Prathipati","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijms.2020.116370_bib92","article-title":"Measurement of total and unbound bictegravir concentrations in plasma and cerebrospinal fluid by UHPLC-MS\/MS","volume":"185","author":"Rigo-Bonnin","year":"2020","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib93","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/00498254.2015.1060372","article-title":"Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans","volume":"46","author":"Bowers","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ijms.2020.116370_bib94","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/cpdd.655","article-title":"A\u00a0Phase 1 study to evaluate the pharmacokinetics and safety of cabotegravir in patients with hepatic impairment and healthy matched controls","volume":"8","author":"Shaik","year":"2019","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.ijms.2020.116370_bib95","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jchromb.2013.11.054","article-title":"A\u00a0sensitive HPLC-MS\/MS method for the determination of dolutegravir in human plasma","volume":"945\u2013946","author":"Bennetto-Hood","year":"2014","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib96","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jchromb.2008.03.022","article-title":"A\u00a0sensitive HPLC-MS-MS method for the determination of raltegravir in human plasma","volume":"867","author":"Long","year":"2008","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ijms.2020.116370_bib99","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cca.2014.02.008","article-title":"Development and bioanalytical validation of a liquid chromatographic-tandem mass spectrometric (LC-MS\/MS) method for the quantification of the CCR5 antagonist maraviroc in human plasma","volume":"431","author":"Emory","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijms.2020.116370_bib97","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1021\/ac301581h","article-title":"Ultrasensitive liquid chromatography-tandem mass spectrometric methodologies for quantification of five HIV-1 integrase inhibitors in plasma for a microdose clinical trial","volume":"84","author":"Sun","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijms.2020.116370_bib98","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpha.2014.10.002","article-title":"Selective and rapid determination of raltegravir in human plasma by liquid chromatography-tandem mass spectrometry in the negative ionization mode","volume":"5","author":"Gupta","year":"2015","journal-title":"J\u00a0Pharm Anal"},{"key":"10.1016\/j.ijms.2020.116370_bib88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpba.2013.10.007","article-title":"LC-MS\/MS structural characterization of stress degradation products including the development of a stability indicating assay of Darunavir: an anti-HIV drug","volume":"89","author":"Rao","year":"2014","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib89","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpba.2014.01.035","article-title":"LC-Q-TOF-MS\/MS determination of darunavir and its metabolites in rat serum and urine: application to pharmacokinetics","volume":"94","author":"Rao","year":"2014","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib90","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1124\/dmd.109.030817","article-title":"Metabolism-mediated drug interactions associated with ritonavir-boosted tipranavir in mice","volume":"38","author":"Li","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bcp.2018.10.012","article-title":"CYP1A1 and 1B1-mediated metabolic pathways of dolutegravir, an HIV integrase inhibitor","volume":"158","author":"Zhu","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijms.2020.116370_bib101","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1039\/C5NJ00698H","article-title":"Quality by design based development of a selective stability-indicating UPLC method of dolutegravir and characterization of its degradation products by UPLC-QTOF-MS\/MS","volume":"39","author":"Kalariya","year":"2015","journal-title":"New J. Chem."},{"key":"10.1016\/j.ijms.2020.116370_bib102","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s13361-014-0884-1","article-title":"Mapping antiretroviral drugs in tissue by IR-MALDESI MSI coupled to the Q Exactive and comparison with LC-MS\/MS SRM assay","volume":"25","author":"Barry","year":"2014","journal-title":"J.\u00a0Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib103","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1124\/dmd.112.048298","article-title":"Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc","volume":"40","author":"Lu","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib104","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1124\/dmd.117.079855","article-title":"Biosynthesis and identification of metabolites of maraviroc and their use in experiments to delineate the relative contributions of cytochrome P4503A4 versus 3A5","volume":"46","author":"Tseng","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib105","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1124\/dmd.107.017517","article-title":"Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist","volume":"35","author":"Ghosal","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijms.2020.116370_bib106","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jpba.2011.06.027","article-title":"Determination of nifeviroc, a novel CCR5 antagonist: application to a pharmacokinetic study","volume":"56","author":"Wu","year":"2011","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ijms.2020.116370_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4711","article-title":"The development and validation of a novel LC-MS\/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid","volume":"34","author":"Dilly Penchala","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijms.2020.116370_bib108","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/oms.1210150202","article-title":"The \u2018even-electron\u2019 rule","volume":"15","author":"Karni","year":"1980","journal-title":"Org. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib109","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jms.1234","article-title":"Even-electron ions: a systematic study of the neutral species lost in the dissociation of quasi-molecular ions","volume":"42","author":"Levsen","year":"2007","journal-title":"J.\u00a0Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib110","series-title":"Mass Spectrometry","isbn-type":"print","first-page":"133","article-title":"Chemical ionization mass spectrometry","author":"Field","year":"1972","ISBN":"https:\/\/id.crossref.org\/isbn\/9780408702669"},{"key":"10.1016\/j.ijms.2020.116370_bib111","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1002\/rcm.3271","article-title":"The even-electron rule in electrospray mass spectra of pesticides","volume":"21","author":"Thurman","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijms.2020.116370_bib112","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.chroma.2010.02.049","article-title":"Basic rules for the interpretation of atmospheric pressure ionization mass spectra of small molecules","volume":"1217","author":"Hol\u010dapek","year":"2010","journal-title":"J.\u00a0Chromatogr. A"}],"container-title":["International Journal of Mass Spectrometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1387380620301664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1387380620301664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T07:34:31Z","timestamp":1761377671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1387380620301664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":113,"alternative-id":["S1387380620301664"],"URL":"https:\/\/doi.org\/10.1016\/j.ijms.2020.116370","relation":{},"ISSN":["1387-3806"],"issn-type":[{"value":"1387-3806","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tandem mass spectrometry of small-molecule antiviral drugs: 1. HIV-related antivirals","name":"articletitle","label":"Article Title"},{"value":"International Journal of Mass Spectrometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijms.2020.116370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116370"}}